Goodman Jesse's Insider Trades & SAST Disclosures
Goodman Jesse's most recent trade in GSK Plc - ADR was a trade of 44 Ords 0.31p done at an average price of $17.1 . Disclosure was reported to the exchange on April 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Goodman Jesse.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 17.07 per share. | 11 Apr 2025 | 44 | 38,812 (0%) | 0% | 17.1 | 751 | Ords 0.31p |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 38.81 per share. | 25 Mar 2025 | 6,842 | 38,768 (0%) | 0% | 38.8 | 265,504 | Ords 0.31p |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 19.64 per share. | 20 Mar 2025 | 498 | 31,926 (0%) | 0% | 19.6 | 9,779 | Ords 0.31p |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Sale or transfer of securities back to the company at price $ 16.67 per share. | 10 Jan 2025 | 36 | 30,224 (0%) | 0% | 16.7 | 600 | Ords 0.31p |
| GSK Plc - ADR | Goodman Jesse | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 16.90 per share. | 20 Dec 2024 | 542 | 30,188 (0%) | 0% | 16.9 | 9,162 | Ords 0.31p |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.54 per share. | 11 Oct 2024 | 28 | 29,646 (0%) | 0% | 19.5 | 547 | Ords 0.31p |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.51 per share. | 23 Sep 2024 | 448 | 29,618 (0%) | 0% | 20.5 | 9,187 | Ords 0.31p |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Sale or transfer of securities back to the company at price $ 19.67 per share. | 12 Jul 2024 | 24 | 29,170 (0%) | 0% | 19.7 | 472 | Ords 0.31p |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.38 per share. | 20 Jun 2024 | 450 | 29,146 (0%) | 0% | 20.4 | 9,172 | Ords 0.31p |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 11,515 | 11,515 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 7,737 | 19,453 (0%) | 0% | 0 | Common Stock | |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.50 per share. | 12 Apr 2024 | 18 | 28,696 (0%) | 0% | 20.5 | 369 | Ords 0.31p |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.95 per share. | 20 Mar 2024 | 438 | 28,678 (0%) | 0% | 21.0 | 9,177 | Ords 0.31p |
| GSK Plc - ADR | Jesse Goodman | Non-Executive Director | Purchase of securities on an exchange or from another person at price $ 20.08 per share. | 12 Jan 2024 | 12 | 27,108 (0%) | 0% | 20.1 | 241 | Ords 0.31p |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 6,473 | 6,473 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 4,425 | 11,716 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 7,688 | 7,688 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 5,197 | 7,291 (0%) | 0% | 0 | Common Stock | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 3,382 | 3,382 | - | - | Stock Option (right to buy) | |
| Intellia Therapeutics Inc | Jesse Goodman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2021 | 2,094 | 2,094 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges